▸SECTION 1
Section 24A of Chapter 94C of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by inserting after subsection (c) the following new subsection:-
(c½) The department shall establish, by rule or regulation, a process by which to include information about the administration of opioid maintenance treatment in the prescription monitoring program, when the inclusion of such information does not conflict with state or federal privacy rules. The purpose of this subsection shall be to ensure that licensed professionals authorized to prescribe controlled substances receive information, through utilization of the prescription monitoring program, about an individual patient’s participation in opioid maintenance treatment prior to issuing a new prescription for an opioid substance other than the substance used for opioid maintenance treatment.
▸SECTION 2
Section 18 of chapter 111E of the General Laws, is hereby amended by inserting after subsection (a) the following new subsection:-
(a½) For each facility that is an opioid treatment program, as defined under 42 CFR Part 8, the facility shall present to each individual entering treatment a form that allows the individual to consent to the release of information, through the prescription monitoring program, about the administration of opioid maintenance treatment at the facility. Said consent form shall be accompanied by information clearly explaining that such consent is not required but is encouraged to improve coordination of services; and by information on how the individual may complete and return the form to the facility or to the department of public health if they elect to give such consent. A record of the individual’s election relative to this form shall be maintained by the facility as part of the record of treatment required by this section. The same form and information shall be presented to the individual upon their discharge from the facility.
Show raw text
SECTION 1. Section 24A of Chapter 94C of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by inserting after subsection (c) the following new subsection:-
(c½) The department shall establish, by rule or regulation, a process by which to include information about the administration of opioid maintenance treatment in the prescription monitoring program, when the inclusion of such information does not conflict with state or federal privacy rules. The purpose of this subsection shall be to ensure that licensed professionals authorized to prescribe controlled substances receive information, through utilization of the prescription monitoring program, about an individual patient’s participation in opioid maintenance treatment prior to issuing a new prescription for an opioid substance other than the substance used for opioid maintenance treatment.
SECTION 2. Section 18 of chapter 111E of the General Laws, is hereby amended by inserting after subsection (a) the following new subsection:-
(a½) For each facility that is an opioid treatment program, as defined under 42 CFR Part 8, the facility shall present to each individual entering treatment a form that allows the individual to consent to the release of information, through the prescription monitoring program, about the administration of opioid maintenance treatment at the facility. Said consent form shall be accompanied by information clearly explaining that such consent is not required but is encouraged to improve coordination of services; and by information on how the individual may complete and return the form to the facility or to the department of public health if they elect to give such consent. A record of the individual’s election relative to this form shall be maintained by the facility as part of the record of treatment required by this section. The same form and information shall be presented to the individual upon their discharge from the facility.